CN Patent
CN102558049A — 一类双香豆素类化合物及其制备方法和用途
Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2012-07-11 · 14y expired
What this patent protects
本发明涉及一种由通式I表示的双香豆素类化合物。其中各取代基的定义如说明书中所述。本发明还涉及上述双香豆素类化合物的制备方法以及其作为蛋白酪氨酸激酶抑制剂在抗肿瘤方面的应用。
USPTO Abstract
本发明涉及一种由通式I表示的双香豆素类化合物。其中各取代基的定义如说明书中所述。本发明还涉及上述双香豆素类化合物的制备方法以及其作为蛋白酪氨酸激酶抑制剂在抗肿瘤方面的应用。
Drugs covered by this patent
- Rezlidhia (OLUTASIDENIB) · Rigel Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.